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Patients with implanted cardiac devices constitute a growing segment of the contem-
porary healthcare practice. Taking care of such a rapidly growing patient population 
constitutes a challenge for all health care providers working in a cardiology ward, 
operating room or primary care practice. Nurses among them have a unique role by 
being the most appropriate persons to provide in-hospital and long term health care, 
education and psychological support to these patients. In-hospital and long-term care 
will ensure an uneventful procedure and a safe discharge as well as early detection of 
device malfunction and late complications. Education of the patient will prevent any 
self or environmental interactions which can adversely affect proper device function 
and will increase his or her adherence to the follow-up treatment. Finally, by provid-
ing psychosocial and emotional support the nursing staff can address the immediate 
concerns of the patient and help him or her cope successfully with the new life situ-
ation. Continuing education is extremely important for nurses counselling patients 
with implanted devices in order to play successfully their role as the continuous link 
to the multidisciplinary team of professionals that guide the oftentimes forgotten hu-
manistic care of these patients. 
Patients with implanted cardiac devices constitute a growing segment of the con-
temporary healthcare practice. According to the American Heart Association, more 
than 170,000 pacemakers and 30,000 implantable cardioverter-defibrillators (ICDs) 
[1] are implanted in the United States each year. Since there were released the results 
of the Multicenter Automatic Defibrillator Implementation Trials (MADIT I and 
II), which found ICD treatment superior to drug therapy alone for the treatment of 
ventricular arrhythmias, the number of implantations of ICDs has quadrupled. [2,3] 
In fact, pacemakers with biventricular pacing capability, some of them combined with 
ICD function, are now being implanted for New York Heart Association Class III and 
IV heart failure patients aiming to improve their quality of life and increase their life 
expectancy [4]. A recent study which pooled data from three trials of 1,080 patients 
found that cardiac resynchronization (biventricular pacemaker-based therapy) de-
creased the risk of death from progressive heart failure (often sudden death from lethal 
arrhythmias) or cardiac transplantation compared to the control group by 5%. [5] 
Similarly, recent data from the registry of the European Heart Rhythm Associa-
tion have shown that, despite the fact that ICDs are underused in Europe, device 
implantation rate exhibits an increased trend in most European countries over the last 
few years [6]. Taking care of such a rapidly growing patient population constitutes a 
challenge for all health care providers working in a cardiology ward, operating room 
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or primary care practice. Nurses among them have a unique 
role by being the most appropriate persons to provide in-hos-
pital and long term health care, education and psychological 
support to these patients. In this review we will present briefly 
some of the aspects of the nurse’s role as counselors of patients 
receiving an implantable cardiac device. 
I N - H O s P I t A L  A N D  L O N G  t E r m  c A r E 
O f  P A t I E N t s  W I t H  I m P L A N t E D 
D E v I c E s .  t H E  N U r s E ’ s  r O L E
The preoperative, intraoperative and postoperative care 
is similar for all patients regardless of which type of implant-
able cardiac device they receive. In the case of an elective 
procedure, typically a generator replacement, the patient is 
admitted for an overnight stay. On the other hand, in case of 
a first-time implantation the patient may have already spent 
several days in the hospital undergoing invasive and non-
invasive diagnostic tests (like coronary angiogram, electro-
physiology study, tilt-table test or Holter monitoring) before 
the criteria for a device implantation have been met. Under 
these circumstances, nurses have the valuable role to closely 
monitor patient’s vital signs and clinical status. This type of 
close monitoring will allow early detection of abnormalities 
preoperatively (like hematomas or occult infections at the 
intravenous lines sites or excess fluid retention in patients with 
heart failure) which have to be thoroughly treated before the 
procedure. In addition, nurses should be kept responsible for 
the meticulous preparation of the patient for the operating or 
procedure room inserting the appropriate lines and admin-
istering chemoprophylaxis and sedation. Knowledge of these 
medication dosages and adverse effects is also mandatory 
[7]. In the procedure room nurses assist the physicians and 
coordinate the operating room tasks performed by the medi-
cal team. They assist initially by placing monitors, starting 
IV lines and positioning.  They also scrub in to pass instru-
ments and assist the operator as well as circulating duties that 
include charting during the case, monitoring the patient and 
communicating with both nurses and physicians in the Car-
diology ward and in the Cardiac Care Unit to coordinate the 
best care for the patient [8]. Postoperative nurse monitoring 
is even more important since it will allow early detection of 
surgical complications like hematoma, infection, dysrrhyth-
mias, pneumothorax and hemothorax. The continuation of 
prophylactic antibiotic coverage for at least 24 hours following 
devices insertion should also be part of the post-implantation 
nursing care [].
The role of a pacemaker nurse as a member of the follow-
up pacemaker clinic has been established in most European 
countries and the USA. A pacemaker nurse is directly in-
volved in the patient follow up evaluation, i.e history taking, 
patient examination and use of the equipment for analysis of 
the device function (12-lead electrocardiography with and 
without magnet, radiography, ambulatory and transtelephonic 
electrocardiographic monitoring, pacemaker programmers) 
[10]. Specific training in this very demanding field is required 
for the pacemaker nurses to accomplish their duties suc-
cessfully and regular re-training to keep up to date with the 
rapidly evolving changes in the device technology seems also 
mandatory. 
Beyond the highly specialized role of a pacemaker nurse, 
any nurse working in a primary health care setting should be 
familiar with at least some general aspects of the pacemaker 
patients follow up care and provide counselling to this patient 
population. For the long term follow up, patients who have a 
pacemaker or an ICD should always be encouraged to carry 
the manufacturer’s identification card with them at all times. 
In this card as well as in the medical record the following 
information must be documented: (a) the manufacturer of 
the device, (b) the model number, (c) the serial number, (d) 
implant date, (e) mode of operation, (f) programmed param-
eters (output, rate, sensitivity), (g) upper and lower rate limits 
for rate responsive devices, (h) type of lead fixation (active or 
passive), (i) unipolar or bipolar lead system, (j) ICD capabil-
ity (shock, pacing, both), and (k) type of delivery system for 
ICD shocks (epicardial or transvenous lead system). At each 
clinic visit, the nurse should inquire about symptoms indica-
tive of arrhythmias, heart failure, and/or ischemia, as well as 
device complications such as the development of dizziness, 
syncope, palpitations, chest pain, and shortness of breath. 
The patient should be specifically queried about arm swelling 
and increased warmth on the side ipsilateral to implantation 
of the endovascular leads, and redness or swelling at the 
device site. 
Reported cardiac device infection rates vary between 
2% and 8%. Treatment typically involves the removal of 
all implanted hardware, in addition to long-term antibiotic 
therapy [11]. Patients should always be questioned about ICD 
discharges (shocks) that have occurred between visits, however 
it is not uncommon for ICDs to reach end-of-life without 
ever delivering a shock for a clinical event. The nurse should 
be aware and inform the other clinic staff that there is no 
danger to them if they come in contact with a defibrillator 
patient during an active ICD discharge. Unintended effects 
of antiarrhythmic drugs can deplete generator life and lead to 
device malfunctioning, such as firing for sinus tachycardia or 
atrial fibrillation with a rapid ventricular response. Electrolyte 
imbalances, including hyperkalemia or hypokalemia, alter the 
heart’s electrical response and must be avoided. Nurses who 
are taking care of patients with implanted cardiac devices who 
are also taking antiarrhythmic drugs, need to monitor drug 
and electrolyte levels on a regular basis (every 2 to 3 months). 
Finally, it is a nurse’s duty to ensure that a chest radiograph is 
obtained post-implantation of either a pacemaker or ICD to 
document baseline location and condition and that it should be 
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repeated on an annual basis or whenever a lead fracture, patch 
crinkling, lead dislodgement, or migration is suspected.
t E A c H I N G  A  P A t I E N t  W I t H  A N 
I m P L A N t E D  c A r D I A c  D E v I c E
Ideally, patient teaching should start preoperatively and 
include the patient’s family and caregivers. Education is es-
sential for a cardiac device recipient and guidelines for nursing 
care have already been published. The underlying assumption 
is that the patient will process and understand the information 
received to help him to adapt his life with a device. While 
recovery from these procedures is generally uncomplicated, 
patients need to learn beforehand how to avoid putting ten-
sion or stress on the leads so that they stay in place. Nurse is 
responsible for instructing the patient to keep the arm on the 
side of the device in a sling for the first day postoperatively, 
even while he sleeps, to completely immobilize it. The patient 
should also instructed that for four to six weeks after the 
surgery, he shouldn’t raise the affected arm over his head, 
lift anything with it, or do any activity that requires abrupt, 
forceful arm movements. [12] Another aspect of teaching is 
to make the patient aware about potential complications. He 
should be told to seek care immediately if he experiences chest 
pain or shortness of breath. He should call his physician if he 
develops swelling of the hands, arms, legs, ankles, or feet, or 
sudden weight gain, such as 1.5 kilograms overnight or up to 
3 kilograms over two or three days. These signs and symptoms 
could indicate, among other things, worsening heart failure, 
which could mean that the device is not functioning properly 
[13]. Nurses should explain how to spot signs of infection and 
tell the patient to call his physician if the surgical site becomes 
red, warm, or has drainage, or if he develops a fever.
The nurse taking care of a patient with an implanted device 
makes sure that he receives the proper identification card and 
carries it with him all the time. He should be instructed to 
show this card to security personnel at airports and anywhere 
where they might have to go through a metal detector, and 
to healthcare professionals before routine exams and during 
emergency care.
Electromagnetic interference (EMI) is another issue pa-
tients need to be counseled on. The nurse has to be familiar 
with the relevant information to communicate it to the patient. 
Electromagnetic interference is defined as “highly-regular 
electrical potentials of low amplitude and high frequency.” 
Experts feel that sources of EMI must be in close proximity 
(within 1.5 meters) to the patients’ devices in order to interfere 
with cardiac device functioning. Sources carrying the highest 
probability levels of interference with cardiac devices include: 
arc welding equipment, electronic muscle stimulators, radio 
transmitters, concert speakers, large motor-generator systems, 
electric drills, and hand-held metal detectors [14]. Dual-cham-
ber pacemakers are programmed to be more sensitive to elec-
trical stimuli than single-chamber pacemakers, and therefore 
have the highest incidence of EMI. Dual-chamber pacers are 
also more likely to revert to asynchronous, fixed-rate pacing 
from EMI exposure. Pacemaker-dependent persons (those 
with an intrinsic heart rate of less than 30 BPM) are most 
likely to experience signs and symptoms attributable to EMI, 
or from the reversion to asynchronous, fixed-rate pacing. 
Electronic-article surveillance systems (the wand-type of 
surveillance often used at airports) affect pacemakers more 
than ICDs, due to the stronger protective-device shielding 
used in ICDs. A 2000 study reported that the interaction 
between pacemakers and electronic-article surveillance sys-
tems occurred in 20% of dual-chamber pacers and 10% of 
single-chamber pacers [15].
On the other hand EMI may cause inappropriate discharge 
of an ICD. The incidence of inappropriate ICD discharges 
was estimated as less than 1% per patient per year in a 2001 
study of 341 ICD patients who were followed retrospectively 
over a 3-year period. Interrogation of the ICDs revealed 
instances where defibrillation (device activation) occurred in 
the absence of either ventricular tachycardia or ventricular 
fibrillation. After excluding other sources of interactions, such 
as muscle contractions, lead fracture, and dislocation of the 
connector, it was concluded that EMI was the sole source of 
electrical interference. The ICD erroneously identified the 
EMI as a life-threatening arrhythmia and delivered a shock 
[16]. The overall number of EMI occurrences is likely under-
estimated; nonsustained episodes of EMI may have occurred 
unbeknownst to the patient or terminated spontaneously 
before the device(s) responded. In addition to documented 
EMI effects, unusual environmental interactions with ICDs 
have occurred, such as during showering, while seated at a 
slot machine, and while using an electric razor. Several of the 
ICD episodes clearly involved EMI, while the origin of others 
is less clear. Older generation ICDs and those implanted in 
the upper abdomen are more likely to be affected by EMI 
than the newer generation ICDs. Better identification of 50 
to 60 cycle (Hz) interference has improved differentiation of 
ventricular arrhythmias and rapid patient movement from 
EMI, which lessens the occurrence of inappropriate ICD 
discharges. Similarly, industry advances in pacemaker lead 
technology, such as bipolar sensing and pacer leads dedicated 
to defibrillation instead of integrated bipolar sensing circuits 
have also reduced EMI. Since most of the patients are aware 
of the potential of EMI they often worry about how certain 
electrical equipment and devices will affect their pacemaker 
or ICD. All patients need to be reassured that most devices 
have features that prevent interference from household appli-
ances, including microwaves and office or shop equipment. 
[17] It is also safe to pass through metal detectors at airports 
and electronic anti-theft devices used by department stores. 
While safe to use, cell phones shouldn’t be carried in a chest 
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pocket directly over an implanted device due to the pos-
sibility of interference from some high-powered digital cell 
phones. However, machinery that contains large magnets or 
strong electromagnetic fields, such as high-voltage electri-
cal transformers, arc welding equipment, and high-current 
industrial equipment, should be avoided. A brief catalogue 
of all potential electrical hazards can be very reassuring for 
most of the patients (Table 1). 
Another activity patients need to be counselled about 
postoperatively is car driving. Initially, a patient with an ICD 
will likely be restricted from driving because of the risk of 
injury—to himself and others—if he loses consciousness [18]. 
A relevant law does not exist in our country. In the US restric-
tions may vary with state law, and patients may be allowed to 
resume driving if they go for a prolonged period—six months 
or one year—without receiving a shock, or without fainting 
when they are shocked. Relevant guidelines have been issue 
from the American Heart Association [1] and the European 
Society of Cardiology [20].
Finally, regardless of which type of device the patient has, 
the importance of taking all medications as prescribed needs 
to be emphasized. The nurse counsellor must explain that 
antiarrhythmics and other drugs work in conjunction with 
pacemakers and ICDs to help control the heart’s rhythm and 
remind patients that those with pacemakers need to follow-up 
with their cardiologist once or twice each year, while those 
with ICDs may need to do so once every three to six months. 
At these visits, the physician will check the device’s settings, 
collect information stored in its memory, and adjust its pro-
gramming if necessary. The patients with advanced heart 
failure and a biventricular pacemaker should be specifically 
instructed to continue their follow-up with both a heart failure 
specialist and an electrophysiologist. 
P s Y c H O L O G I c A L  s U P P O r t  f O r 
P A t I E N t s  W I t H  A N  I m P L A N t E D 
c A r D I A c  D E v I c E
The majority of patients who are implanted with a device 
experience a desirable quality-of-life and a high acceptance 
rate especially when their symptoms improve postoperatively. 
More specifically, the group of patients with a VVI or DDD 
pacemaker report an acceptable health related quality of life. 
Nevertheless, a recent Swedish study showed that the most 
socially vulnerable groups of the pacemaker population like 
women, single persons as well as elderly and retired persons 
experience worsening of their life status after a pacemaker 
implantation [21]. On the other hand, thirty to fifty percent 
of patients who had an ICD implanted reported some degree 
of negative effect, such as fear, anxiety, and depression [22]. 
Additionally, lifestyle changes that affect driving, sexual ac-
tivity, social interactions, physical appearance and physical 
activity further complicate the life of the recipient. Younger 
implanted patients, some as young as 4 years of age, those <50 
years of age, and those who experience high rates of shocks 
have been identified as being at special risk for development 
of psychological distress and poor health outcomes [23].
The major psychosocial concerns, no matter what the age 
of the patient, include device dependency, fear of shock, poor 
body image, device malfunction, significant lifestyle changes, 
unpredictability of therapy, and isolation. These concerns may 
translate into anxiety disorder, depression, shock expectancy, 
post traumatic stress disorder, panic attacks, and phobias 
[24]. It appears that anxiety and depression increase with the 
frequency of shock episodes for the patients who carry an 
ICD. Anxiety about the ICD firing is closely associated with 
the occurrence of depression, while avoidance of activities is 
associated with anxiety [25]. “Worry” about the ICD and a 
belief that ICD firing can be predicted is associated with anxi-
ety sensitivity. The patient develops a belief that shock can be 
predicted. Monitoring of signs of impending shock begin to in-
crease. This leads to hypervigilance regarding body sensations 
that are often provoked by anxiety. This can lead to increased 
awareness of body sensations, which in turn may lead to the 
individual associating unrelated chance sensations with shock 
[26]. When a patient feels anxious or depressed he also begins 
to feel less secure and less satisfied with the ICD therapy 
and report a decrease in quality of life. The resulting anxiety 
promotes increased avoidance behavior, fear of increasing 
autonomic arousal, sleep disturbances, sexual dysfunction, 
increased irritability and difficulty concentrating. 
Researchers [27,28] agree that psychological and emo-
tional support for the patient with an implanted device is an 
important aspect of care that has not been given as much 
t AbLE 1. Main sources of Electromagnetic  interference 
with implantable cardiac devices
Electrical haz-
ards to be  
aware of
Electrical hazards to 
avoid
Electrical appli-




Working under the 








Electrocautery – in the 
operating room or in 
the dentist’s office
Electric blankets  
and heating pads
Arc welding Computers
Therapeutic radiation Radios, TVs  
and stereos
COUNSELING PATIENTS WITH IMPLANTED CARDIAC DEVICES: THE NURSE’S ROLE
27
attention as is needed. Providing the implanted patient time 
to verbalize fear or concerns related to the device, as well 
as allowing discussion of the meaning of his or her illness, 
is an important aspect of a psychological plan for these 
patients. The nursing staff as part of the team taking care 
of the patient with an implanted device should give informa-
tion concerning the device implant as soon as the recipient 
is informed the device is necessary. The patient should be 
provided an opportunity to hold the device in order to see 
what it looks and feels like. Patients need to be taught what 
to expect immediately post-op, during recovery, long-term 
effects, and any limitations that will be present post-implant. 
Patient questions concerning sexual activity, anxiety and guilt, 
device failure and potential death must be dealt with openly 
and honestly. The family of the patient must be included in 
this education process. Families of the patient experience 
some of the same fear and anxiety felt by the device recipi-
ent. Reports of parents of children with implants becoming 
overprotective and spouses exhibiting hypervigilant behaviors 
have been widely reported [2]. Teaching coping skills related 
to ICD discharge, and increasing knowledge and under-
standing of the disease process that precipitates the need 
for the device, provides the patient with a degree of control. 
Interventions of this type also facilitate self-management. 
Eads et al. [30] have suggested using seven unique principles 
to facilitate psychosocial adjustment during routine follow-up 
visits for patients with an ICD. These seven principles, which 
can easily be adopted also for the patients with carry a pace-
maker or a cardiac resynchronization device, are:
1: Define the problem. Allow the patient to pinpoint specific 
concerns. Some specific concerns that would not ordinarily be 
identified are memory difficulties, difficulty sleeping, overpro-
tective family, and sexual difficulties, as well as depression, 
fear of shock, and fear of device malfunction. Questioning 
patients about personal concerns during routine follow-up 
visits gives an opportunity to attain needed information, ex-
press feelings, and simply chat about the device. Patients need 
a chance to tell their story. Questions such as “What are your 
concerns about having a pacemaker/ ICD?” and “Are you wor-
ried about your pacemaker/ICD?” may stimulate discussion 
between the pacemaker/ICD clinic staff and the patient. 
2: Provide information. This may be one of the most effec-
tive methods of increasing a sense of control. Patients who felt 
better prepared for living with the device after implantation 
had better medical and psychosocial outcomes. On the other 
hand, erroneous beliefs about the device may result in coun-
terproductive behavior, such as attempts to predict shock or 
activities that are believed to induce shock. For some patients, 
this may translate into a debilitating pattern consisting of 
progressive limitations in activities and escalation of fearful 
thoughts.  Ongoing patient contact, along with medical knowl-
edge and expertise, puts the nursing staff in an exceptional 
position to provide information to enhance patient perceptions 
of control over reactions to their medical diagnosis. Typically, 
targets of education for the patient comprise of explanations 
about the medical condition, device function and action, and 
discussions about lifestyle change that come about as a result 
of the implant. For example, fear of triggering the device dur-
ing sexual activity is a fear in approximately 50% of patients. 
Addressing this subject directly is important. Sex is a natural 
part of life, and this type of physical exertion is particularly 
anxiety-provoking for patients. It is typically related to the er-
roneous assumption that sexual activity represents an extreme 
level of exertion. Interventions may normalize feelings about 
sexual activity. Nurse counselling a patient with an implanted 
device may provide education regarding safe levels of sexual 
activity. Discussing the role of regular exercise may lead to 
increased confidence about engaging in sex. Information 
concerning other sources of sexual dysfunction, i.e., medica-
tions and vascular disease it is also important. Starting the 
discussion with the question “Do you have any questions for 
me about the pacemaker/ICD?” may be a good way to engage 
use of this principle.
3: Create team support. Social support is a significant en-
hancement to adjusting to cardiac illness. Ensuring trusting 
and supportive relationships with family and friends on whom 
the device patient can depend is important for adjusting to the 
implant. It is important to note that healthcare providers are 
psychosocial providers and significant sources of support to 
this patient group. Patients especially value the relationship 
that is developed with the people who fully understand their 
needs. Even so, the patient may still need an invitation to talk 
about and express their needs; therefore, open communication 
is very important. Open this discussion with “We would like 
you to think of yourself as part of your treatment team.”
4: Normalize fears. Approximately 13–38% of ICD patients 
experience diagnosable levels of anxiety, and nearly one-third 
report fear of shock. ICD shock can be extremely uncomfort-
able, and those patients that receive more than one shock 
consecutively may be at risk for a high incidence of psycho-
social complications. Engaging the ICD patient in discussion 
that normalizes emotions enables the follow-up staff to help 
the patient talk about their fears and other reactions relating 
to the ICD. The follow-up staff can then assure the patient 
that fear is an expected part of having an ICD implant and 
is neither a sign of poor outcomes nor an abnormal occur-
rence. When fear is labeled as a safe and inevitable part of 
treatment, patients become less sensitive to the presence of 
fear. Accepting fear may enhance the patient’s confidence to 
resume a normal life despite the threat of shock. The statement 
“Feeling stressed about the device is a normal reaction” may 
spark this discussion.
5: Encourage emotional release. Patients who avoid talking 
about the negative aspects of their device are at increased 
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risk of ongoing emotional distress. Merely affording a patient 
the opportunity to discuss worrisome issues with an open 
and empathic listener allows for emotional catharsis. Asking 
“Can we discuss your feelings about your device?” may lead 
to relief from the burden of harboring unexpressed concerns, 
and may precede resolution of uncertainties connected with 
the device. As important as this principle is, implementation 
is time-intensive. The nursing staff might consider allowing 
brief discussion periods with the patient on a routine basis, 
which may help in decreasing extreme emotional outburst that 
take more time with which to deal.)
6: A statement such as “It is possible to return to your normal 
activities after you recover” will instill hope. It is very important 
to assure the implanted patient that the physical discomfort 
and emotional distress they are experiencing will more than 
likely diminish with time. Overall, quality of life and psychoso-
cial functioning in the areas of emotional behavior, alertness, 
and social interaction temporarily decline six months post 
implant. Follow-up studies at 12 months have found that all 
areas of functioning return to baseline. 
7: Encourage patients to take action. The follow-up staff 
can effectively foster self-efficacy behaviors in patients by 
providing instruction about self-care and by encouraging the 
belief that patients possess the capacity to successfully care 
for themselves. It is psychologically enhancing for patients to 
resume everyday activities after receiving the device. There 
are times patients may need encouragement to maintain a 
degree of physical exertion over time, including exercise or 
sexual activity.
Other approaches for psychosocial intervention of the pa-
tient implanted with a cardiac device have also implemented. 
One such approach is the initiation of cognitive behavioral 
therapy [31] while alternative therapies such as progressive 
muscular relaxation, breathing techniques, deep relaxation, 
and self hypnosis, taught early and re-enforced through out 
follow-up, have helped the patient cope with the new stress of 
an implant [32]. However, regardless of the type of interven-
tion chosen to offer psychosocial and emotional support to 
the recipients of an implantable cardiac device, the role of 
the nurses as educators and advocates for this unique and 
challenging population is extremely important, and are the 
continuous link to the multidisciplinary team of professionals 
that guide the oftentimes forgotten humanistic care of these 
patient [33]. 
c O N c L U s I O N s
With more and more patients receiving pacemakers, ICDs, 
and combination devices a need for multidisciplinary approach 
to meet these population specific needs becomes obvious. 
Nurses who have a holistic outlook on patient care can play a 
key role in this health care team by supporting these patients 
and their families during as well as after implantation. To ac-
complish this task nursing intervention must be multi-level. 
In-hospital and long term care will ensure an uneventful pro-
cedure and a safe discharge as well as early detection of device 
malfunction and late complications. Education of the patient 
will prevent any self or environmental interactions which can 
adversely affect proper device function and will increase his 
adherence to the follow-up treatment. Finally, by providing 
psychosocial and emotional support the nursing staff can 
address the immediate concerns of the patient and help him 
cope successfully with his new life situation. To be able to meet 
the requirements of this complex role is essential that nurses 
taking care of patients with implanted devices receive training 
and continuing education in this rapidly evolving field. 
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